XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance, December 31, 2021 (in shares) at Dec. 31, 2020 1      
Balance, December 31, 2021 at Dec. 31, 2020 $ 0 $ 100 $ (472,260) $ (472,160)
Common stock issued for cash (in shares) 7,129,887      
Common stock issued for cash $ 72 6,415,139 0 6,415,210
Net loss $ 0 0 (658,510) (658,510)
Common stock retained in merger (in shares) 5,635,348      
Common stock retained in merger $ 56 53,509,466 0 53,509,522
Offering costs netted against proceeds $ 0 (156,443) 0 (156,443)
Balance, March 31, 2022 (in shares) at Mar. 31, 2021 12,765,236      
Balance, March 31, 2022 at Mar. 31, 2021 $ 128 59,768,262 (1,130,770) 58,637,619
Balance, December 31, 2021 (in shares) at Dec. 31, 2020 1      
Balance, December 31, 2021 at Dec. 31, 2020 $ 0 100 (472,260) (472,160)
Net loss       (2,402,064)
Balance, March 31, 2022 (in shares) at Sep. 30, 2021 14,719,983      
Balance, March 31, 2022 at Sep. 30, 2021 $ 147 76,222,880 (2,874,324) 73,348,703
Balance, December 31, 2021 (in shares) at Mar. 31, 2021 12,765,236      
Balance, December 31, 2021 at Mar. 31, 2021 $ 128 59,768,262 (1,130,770) 58,637,619
Common stock issued for cash (in shares) 1,936,813      
Common stock issued for cash $ 19 16,322,030 0 16,322,049
Net loss 0 0 (893,079) (893,079)
Offering costs netted against proceeds $ 0 (31,572) 0 (31,572)
Balance, March 31, 2022 (in shares) at Jun. 30, 2021 14,702,049      
Balance, March 31, 2022 at Jun. 30, 2021 $ 147 76,058,720 (2,023,849) 74,035,018
Common stock issued for cash (in shares) 17,934      
Common stock issued for cash $ 0 43,028 0 43,028
Stock based compensation 0 121,132 0 121,132
Net loss $ 0 0 (850,475) (850,475)
Balance, March 31, 2022 (in shares) at Sep. 30, 2021 14,719,983      
Balance, March 31, 2022 at Sep. 30, 2021 $ 147 76,222,880 (2,874,324) 73,348,703
Balance, December 31, 2021 (in shares) at Dec. 31, 2021 14,912,189      
Balance, December 31, 2021 at Dec. 31, 2021 $ 149 81,866,075 (8,124,360) 73,741,864
Common stock issued for cash (in shares) 50,000      
Common stock issued for cash $ 1 119,999 0 120,000
Common stock issued for lawsuit settlement (in shares) 38,484      
Common stock issued for lawsuit settlement $ 0 197,431 0 197,431
Stock based compensation 0 1,614,845 0 1,614,845
Net loss $ 0 0 (2,936,862) (2,936,862)
Balance, March 31, 2022 (in shares) at Mar. 31, 2022 15,000,673      
Balance, March 31, 2022 at Mar. 31, 2022 $ 150 83,798,350 (11,061,222) 72,737,278
Balance, December 31, 2021 (in shares) at Dec. 31, 2021 14,912,189      
Balance, December 31, 2021 at Dec. 31, 2021 $ 149 81,866,075 (8,124,360) 73,741,864
Net loss [1]       (5,437,212)
Balance, March 31, 2022 (in shares) at Sep. 30, 2022 15,021,088      
Balance, March 31, 2022 at Sep. 30, 2022 $ 150 83,923,350 (13,561,572) 70,361,928 [2]
Balance, December 31, 2021 (in shares) at Mar. 31, 2022 15,000,673      
Balance, December 31, 2021 at Mar. 31, 2022 $ 150 83,798,350 (11,061,222) 72,737,278
Net loss $ 0 0 (1,176,582) (1,176,582)
Balance, March 31, 2022 (in shares) at Jun. 30, 2022 15,000,673      
Balance, March 31, 2022 at Jun. 30, 2022 $ 150 83,798,350 (12,237,804) 71,560,696
Common stock issued for lawsuit settlement (in shares) 20,415      
Common stock issued for lawsuit settlement $ 0 125,000 0 125,000
Net loss $ 0 0 (1,323,768) (1,323,768) [1]
Balance, March 31, 2022 (in shares) at Sep. 30, 2022 15,021,088      
Balance, March 31, 2022 at Sep. 30, 2022 $ 150 $ 83,923,350 $ (13,561,572) $ 70,361,928 [2]
[1] The Consolidated Statements of Operations for the three and nine months ended September 30, 2022 have been restated. See Note 12.
[2] The Consolidated Balance Sheet as of September 30, 2022 has been restated. See Note 12.